Product Information
LARIN 1.5 MG-30 MCG TABLET is a generic product labeled by NorthStar Rx LLC, priced at $0.3358 per EA under NDC 16714040703. Its NADAC has been published 624 times since Oct 22, 2014.
FDA first approved this application on Mar 20, 2014. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Manufacturer
NorthStar Rx LLCNDC
16714040703
Classification
Generic
Dosage Form
KIT
Effective Date
9/23/2026
Approval Type
Generic (ANDA)
FDA Application
ANDA202996FDA Approved
3/20/2014
TE Code
AB
On Market Since
3/20/2014
Price Statistics
The NADAC for LARIN 1.5 MG-30 MCG TABLET has been published 624 times since Oct 22, 2014, and over the history we have for it it has declined 58.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3358 per EA |
|---|---|
| All-time high | $0.9128 (Sep 14, 2016) |
| All-time low | $0.3066 (Jul 17, 2024) |
| 52-week high | $0.3923 |
| 52-week low | $0.3344 |
| Median price | $0.5914 |
| Average price | $0.5983 |
| Largest weekly change | +67.3% (Aug 21, 2024) |
| Weeks tracked | 624 |
| Tracking since | Oct 22, 2014 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 49% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
NorthStar Rx LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Norethindrone Acetate/Ethinyl Estradiol market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of LARIN 1.5 MG-30 MCG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LARIN 1.5 MG-30 MCG TABLET, manufactured by NorthStar Rx LLC, is $0.3358 per EA (NDC 16714040703), effective Sep 30, 2026.
How has the price of LARIN 1.5 MG-30 MCG TABLET changed over time?
Over the history we have for it, the NADAC for LARIN 1.5 MG-30 MCG TABLET has declined 58.2%. It has been tracked across 624 weekly CMS publications since Oct 22, 2014.
What are the highest and lowest recorded NADAC prices for LARIN 1.5 MG-30 MCG TABLET?
Since Oct 22, 2014, the NADAC for LARIN 1.5 MG-30 MCG TABLET has ranged from a low of $0.3066 (Jul 17, 2024) to a high of $0.9128 (Sep 14, 2016), with a median of $0.5914 per EA.
Are there cheaper alternatives to LARIN 1.5 MG-30 MCG TABLET?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, MICROGESTIN 21 1-20 TABLET, is $0.1703 per EA — about 49% below LARIN 1.5 MG-30 MCG TABLET.
Who manufactures LARIN 1.5 MG-30 MCG TABLET?
LARIN 1.5 MG-30 MCG TABLET (NDC 16714040703) is labeled by NorthStar Rx LLC, and CMS classifies it as a generic product.